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Abstract
Background: The number of patients presenting for total knee replacement who are classified as obese is increasing. The
functional benefits of performing TKR in these patients are unclear.
Aim: To assess the influence pre-operative body mass index has upon knee specific function, general health status and
patient satisfaction at 3 years following total knee replacement.
Design: Retrospective comparative cohort study using prospectively collected data from an institutional arthroplasty
register.
Methods: 1367 patients were assessed using the Western Ontario and McMaster University Osteoarthritis Index (WOMAC)
and Medical Outcomes Trust Short Form-36 (SF-36) scores supplemented by a validated measure of satisfaction pre-
operatively and subsequently at 1,2 and 3 year post-operatively. Comparisons were made by dividing the cohort into 4
groups based on body mass index (BMI) 18.5–25.0 kg/m2 (n = 253);.25.0–30.0 kg/m2 (n = 559);.30.0235.0 kg/m2
(n = 373);.35.0 kg/m2 (n = 182).
Results: Despite lower pre-operative, 1 and 3 year WOMAC and SF-36 scores patients with the highest BMIs .35.0 kg/m2
experienced similar improvements to patients with a ‘normal‘ BMI (18.5–25.0 kg/m2) at 1 year (Difference in WOMAC
improvement = 0.0 (95%CI 25.2 to 5.2), p = 1.00) and this improvement was sustained at up to 3 years (Difference in 1 year
to 3 year improvement = 2.2 (95%CI: 22.1 to 6.5), p = 1.00). This effect was also observed for the SF-36 mental and physical
component scores. Despite equivalent functional improvements levels of satisfaction in the .35.0 kg/m2 group were lower
than for any other BMI group (.35.0 kg/m2 = 84.6% satisfied versus 18.5–5.0 kg/m2 = 93.3% satisfied,p = 0.01) as was the
proportion of patients who stated they would have the operation again (.35.0 kg/m2 = 69.6% versus 18.5–25.0 kg/
m2 = 82.2%,p = 0.01).
Conclusion: Obese and morbidly obese patients gain as much functional benefit from total knee replacement as patients
with lesser body mass indexes. This benefit is maintained for up to 3 years following surgery. However, these patients are
less satisfied with their knee replacement and almost a third would not have the operation again.
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Introduction
Obesity is a global epidemic [1,2]. In England, greater than
26% of the population are now obese (Body Mass Index (BMI)
$30 kg/m2) [1] mirroring findings from the rest of Europe [2].
Rates of obesity are increasing and it is predicted that by the end
of 2012 greater than 30% of the population of England will be
classified as obese [3]. Obesity has a detrimental effect on knee
joint function [4]. The increased loads associated with increasing
body mass are causative in the development of degenerative knee
arthritis [4–7]. Growth in the proportion of the population with
obesity, combined with an increased demand for knee arthroplasty
as we service an increasingly elderly population, will inevitably
lead to a rise in the number of obese patients requesting Total
Knee Replacement (TKR).
The treatment of obese patients currently poses a dilemma for
the operating surgeon. The timing of surgery, the role of bariatric
surgery and the issue of whether surgeons should withhold knee
PLOS ONE | www.plosone.org 1 March 2013 | Volume 8 | Issue 3 | e59079
replacement for patients above specific BMI thresholds is a matter
of on-going debate [8–11]. Historically both obese (BMI $30 kg/
m2) and morbidly obese (BMI $40 kg/m2) patients have suffered
a higher incidence of complications [10,11] and lower rates of
implant survival (5-year survival rates = 74%) following TKR [12].
However this view has been challenged by contemporary reports
of equivalent rates of complications [9,13] and mid-term survival
[14,15] irrespective of the patient’s pre-operative BMI. These
reports have also suggested that morbidly obese patients achieve
the same functional improvements (Oxford Knee Score, Euroqol-
5D) as patients with a ‘‘normal’’ BMI (BMI 18.5 to 25 kg/m2) [9].
However the validity of this conclusion is limited by a short
duration of follow up (median 7 months) and it therefore remains
unclear whether this finding is generalisable to longer term
functional outcomes.
The financial and resource burdens associated with elective
surgical procedures mean it is imperative that operations remain
cost-effective irrespective of the patient cohort presenting for
surgery. Central to this is the ability to demonstrate sustained
improvements in the patient’s functional level and quality of life
following surgery. For obese and morbidly obese patients un-
dergoing TKR this information is currently lacking. We therefore
aimed to address this by assessing the influence pre-operative BMI
has upon 1) knee specific function 2) general health status and 3)
patient satisfaction up to 3 years following TKR.
Materials and Methods
Ethics Statement
The Freeman Joint Registry is an on-going clinical audit which
commenced July 2003 as a mechanism for monitoring outcomes
following hip and knee replacement. Prior to surgery all patients
receive a patient information sheet and informed consent is
obtained covering the collection, storage and subsequent analysis
of data. The project was registered with the institutional research
board (Project ID number: 3290). This analysis was covered by the
terms of the registry and was performed on anonomised data
without need for additional patient contact. It was therefore
performed as a service evaluation without need for formal ethical
approval. The study was conducted in accordance with the
declaration of Helsinki and the guidelines for good clinical
practice.
This analysis was performed as a retrospective comparative
cohort study using prospectively collected data from a single centre
institutional arthroplasty register. The registry routinely collects
pre-operative patient demographic details (age, gender, presences
of co-morbidities, self-reported height and weight) in addition to
baseline functional outcomes (Western Ontario and McMaster
University Osteoarthritis Index (WOMAC) [16], Medical Out-
comes Trust Short Form-36 (SF-36) [17]). Pre-operative assess-
ment was performed within 6 weeks of surgery. Post-operatively
patients were reviewed annually out to 3 years using WOMAC
and SF-36 scores supplemented by measures of patient reported
satisfaction [18]. Post-operatively patients were reviewed in the
outpatient clinic at 1,2 and 5 years. The assessments at 1 and 2
years were therefore performed in the outpatient clinic, whereas
the 3 year assessment was performed using a postal questionnaire
identical to questionnaires completed in the outpatient clinic at the
earlier time points.
This study was interested in assessing mid-term functional
outcomes and as such only those patients who had reached the
threshold for 3 year review were included. All patients undergoing
primary TKR that were entered onto the registry between July
2004 and August 2008 were included irrespective of the indication
for surgery (n = 1902). All patients underwent cemented TKR
using either Press Fit Condylar (PFC) (Depuy, Warsaw Indiana,
USA) or Triathlon (Stryker, Marwah New Jersey, USA) knee
implants. From this we excluded 253 patients with missing BMI
data and 282 patients with missing or invalid pre-operative or 1
year post-operative WOMAC/SF-36 data. After exclusions this
left a cohort of 1367 patients with a recorded BMI and complete
pre-operative and 1 year post-operative data for analysis. To
ensure our exclusion criteria had not biased the study cohort we
compared the demographic details of this cohort with the details of
those patients who were excluded. These groups were similar for
patient age (p = 0.85), gender (p = 0.43) and co-morbidity score
[19] (p = 0.43) suggesting that the group included in the analysis
was representative of the total population of patients presenting for
TKR at our institution. The mean BMI of the study cohort
(29.5 kg/m2) was also similar to the mean BMI of the 282 patients
excluded due to lack of WOMAC/SF-36 data (29.2 kg/m2)
(p = 0.42). Of the 1367 patients with 1 year functional outcome
data, 1180 (86.3%) and 1056 (77.2%) also had outcome data at 2
and 3 years respectively.
The institutional registry uses the WOMAC score [16] to assess
knee specific outcomes. The WOMAC score assesses 24 elements
divided into 3 subscales (pain, stiffness, function) which are
combined to produce an overall measure of knee health. General
health was evaluated using the SF-36 [17], a generic health
measure, which assesses both physical and mental health status.
Table 1. Patients demographics for the study cohort.
BMI group
Variable
Normal (BMI: 18.5 to
25.0 kg/m2)
Overweight (BMI: .25.0
to 30.0 kg/m2)
Obese class I (BMI: .30.0 to
35.0 kg/m2)
Obese class II & III
(BMI: .35.0 kg/m2) p value
n 253 559 373 182
Age (Years)
Mean (S.D) 71.1 (9.8) 70.6 (9.4) 67.2 (8.9) 64.3 (7.7) ,0.01
Gender
Male: Female 116 (46%): 137 (54%) 240 (43%): 319 (57%) 157 (42%): 216 (58%) 72 (40%): 110 (60%) 0.61
Comorbidity Index
Median (Range) 2 (0–11) 3 (0–16) 3 (0–12) 4 (0–12) ,0.01
Groups were compared using ANOVA for continuous variables (Age, Co-morbidity) and the Chi-Squared test for categorical variables (Gender).
doi:10.1371/journal.pone.0059079.t001
BMI and Function after Knee Replacement
PLOS ONE | www.plosone.org 2 March 2013 | Volume 8 | Issue 3 | e59079
For both of these outcomes the final scores were transformed to
produce a 0 to 100 point scale (100 best). Using this method the
minimally clinically important difference (MCID) for these two
scales are at least 15 points for the WOMAC and 10 points for the
SF-36 [20].
In addition to the WOMAC and SF-36 patients were also asked
to complete a short self-report questionnaire evaluating their level
of satisfaction alongside questions relating to quality of life and
whether they would undergo knee replacement again. The
satisfaction questionnaire consists of four items focusing on
satisfaction with improvement in ability to perform home or yard
work, ability to perform recreational activities, the extent of pain
relief and overall satisfaction with joint replacement [18].
Responses to each of the items are scored using a 4-point Likert
scale with using the answers ‘Very satisfied/‘Somewhat satisfied’/
‘Somewhat dissatisfied’/‘Very dissatisfied’. This outcome tool has
been validated for the assessment of satisfaction in patients
following TKR [18]. The quality-of-life question asked patients:
‘‘How much did the knee replacement surgery improve the quality
of your life?’’ to which there are five possible responses ‘A Great
improvement’/‘A Moderate improvement’/‘A Little improve-
ment’/‘No improvement at all’/‘The quality of life is worse’.
Patients were also asked ‘‘Knowing how well you have done
following your knee replacement surgery would you have the same
surgery again?’’ with possible responses ‘Yes’/‘No’/‘Unsure’.
Prior to analysis each patient had their BMI calculated from
their self-reported height and weight [21]. To allow comparison
between patients with different BMIs we intended to classify the
study cohort into five groups based on the World Health
Organisation criteria [22] (normal BMI= 18.5 to 25.0 kg/m2
(n= 253); overweight.25.0 to 30.0 kg/m2 (n= 559); obese class
I.30.0 to 35.0 kg/m2 (n= 373); obese class II.35.0 to 40.0 kg/
m2 (n= 144); obese class III.40.0 kg/m2 (n = 38). Power calcu-
lation based on the observed distributions of the WOMAC and
SF-36, the MCID for these two scores, a power of 0.8 and
a significance level of 0.05 demonstrated that for a 5 group
comparison we required a minimum of 49 patients in each group.
As the numbers in the obese class III group were below this we
decided to combine the obese class II and III groups to ensure our
analysis was sufficiently powered. Patient co-morbidity was
assessed using a validated, medical record-based co-morbidity
instrument [19]. This tool combines responses to 12 questions
concerning current and subsequent health status to produce a co-
morbidity index ranging from 0 to 24. Baseline characteristics for
the four groups are given in Table 1.
Statistical Analysis
Continuous variables were compared using one-way ANOVA
with post hoc between groups comparisons performed using the
Tukey honestly significant difference (HSD) test. Chi-squared tests
Figure 1. Mean WOMAC score for each of the 4 BMI groups.
doi:10.1371/journal.pone.0059079.g001
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were used for binary and categorical variables. The patient
demographics differed between the four BMI groups (Table 1). To
limit the possible confounding effects of differences in age and co-
morbidity we also calculated adjusted differences in the WOMAC
and SF-36 scores for these groups using the residuals of linear
models including the patient demographics (age, gender and co-
morbidity). SPSS version 19 (IBM corporation, Armonk, New
York, USA) was used to carry out the analysis with p,0.05
considered as statistically significant.
Results
Patient demographics for each of the four BMI categories are
given in Table 1. Patients classified as obese were younger
(p,0.01) and had a greater co-morbidity score (p,0.01) than
patients classified as normal or overweight.
WOMAC
For the entire study cohort the mean pre-operative and 3 year
WOMAC were 36.8 (95%CI 35.9 to 37.6) and 74.4 (95%CI 73.3
to 75.4) respectively. At 1 year following surgery the mean
WOMAC demonstrated a significant improvement from the pre-
operative level (37.9 (95%CI 36.8 to 38.9) but thereafter the score
plateaued (change between 1 and 3 years (20.3 (95%CI 21.1 to
0.6).
A breakdown of WOMAC scores for each of the 4 BMI groups
is given in table 2 and figure 1. There were significant differences
in the absolute WOMAC scores between the 4 groups at each time
point (all p,0.01) with a consistent trend for scores to decrease as
BMI increased. Post hoc between group comparisons were made
using the Tukey HSD method. This demonstrated that the mean
pre-operative and 1 year post-operative WOMAC scores were
significantly lower for the obese class II/III group when compared
to the other three BMI groups (difference versus normal BMI: Pre-
operative = 10.4 (95%CI: 6.3 to 14.4),p,0.01; 1 year = 10.3
(95%CI: 5.5 to 15.1),p,0.01; difference versus overweight: Pre-
operative = 9.0 (95%CI: 5.5 to 12.6),p,0.01; 1 year = 8.4 (95%CI:
4.2 to 12.6),p,0.01; difference versus obese I: Pre-operative = 6.1
(95%CI: 2.3 to 9.8),p,0.01; 1 year = 7.1 (95%CI: 2.7 to
11.6),p,0.01). The mean WOMAC scores for the overweight
group were comparable to the scores for the normal BMI group at
all of the time points (p = 0.69 pre-operatively and p= 0.55 at 1
year). The obese I group had lower pre-operative scores when
compared to both the normal BMI group (difference = 4.3
(95%CI: 0.9 to 7.6),p,0.01) and overweight group (differ-
ence = 2.9 (95%CI: 0.2 to 5.7),p = 0.03). However their 1 year
WOMAC scores were similar (difference versus normal BMI
group= 3.2 (p = 0.17), difference versus overweight group= 1.3
(p = 0.75).
Despite lower scores at each time point the change in the
WOMAC was similar for each of the 4 groups (Table 2).
Comparisons of the improvements from the pre-operative baseline
to 1 year and from 1 year to 3 years demonstrated the changes in
scores were marginally greater for the obese II/III groups when
compared to the normal BMI group. However, this difference was
not statistically significant (difference between obese II/III versus
normal BMI: Pre-operative to 1 year change = 0.0 (25.1 to
5.1),p = 1.00; 1 year to 3 year change= 2.2 (95%CI 22.0 to
6.4),p = 0.54). This finding was accentuated after adjusting the
data for the differences in age, gender and co-morbidity observed
between these groups using regression (Adjusted difference
between obese II/III versus normal BMI: Pre-operative to 1 year
change= 0.9 (22.1 to 3.9),p = 1.00; 1 year to 3 year change= 2.6
(95%CI 0.2 to 5.0),p = 0.03). This suggests that the obese II/III
patients improved to the same extent as the normal BMI patients
and that the improvement was more sustained in the obese II/III
group.
Table 2. Comparison of the WOMAC, SF-36 PCS and SF-36 MCS scores for the 4 BMI groups.
BMI group
Variable
Normal (BMI: 18.5 to
25.0 kg/m2)
Overweight (BMI: .25.0
to 30.0 kg/m2)
Obese class I (BMI: .30.0
to 35.0 kg/m2)
Obese class II & III
(BMI: .35.0 kg/m2)
p value
(ANOVA)
n 253 559 373 182
Mean WOMAC
Pre-op 39.9 (95%CI: 37.7 to 42.1) 38.5 (95%CI: 37.1 to 39.9) 35.6 (95%CI: 34.2 to 37.1) 29.5 (95%CI: 27.3 to 31.7) ,0.01
1 year 77.7 (95%CI: 75.3 to 80.1) 75.8 (95%CI: 74.2 to 77.3) 74.5 (95%CI: 72.6 to 76.4) 67.4 (95%CI: 64.4 to 70.3) ,0.01
Change Pre op to 1 year 37.8 (95%CI: 35.4 to 40.3) 37.2 (95%CI: 35.5 to 38.9) 38.9 (95%CI: 36.8 to 40.9) 37.8 (95%CI 34.8 to 40.9) 0.70
Change 1 year to 3 years 21.7 (95%CI: 23.7 to 0.2) 20.2 (95%CI: 21.5 to 1.2) 0.3 (95%CI: 21.3 to 1.9) 0.4 (95%CI 22.1 to 3.0) 0.40
Mean SF-36 PCS
Pre-op 28.0 (95%CI: 27.0 to 28.9) 28.1 (95%CI: 27.4 to 28.7) 26.8 (95%CI: 26.1 to 27.5) 25.7 (95%CI: 24.7 to 26.8) ,0.01
1 year 37.9 (95%CI: 36.5 to 39.2) 38.0 (95%CI: 37.1 to 38.9) 36.4 (95%CI: 35.4 to 37.5) 33.0 (95%CI: 31.5 to 34.4) ,0.01
Change Pre op to 1 year 9.9 (95%CI: 8.7 to 11.1) 10.1 (95%CI: 9.1 to 10.8) 9.6 (95%CI: 8.7 to 10.6) 7.2 (95%CI: 5.8 to 8.6) ,0.01
Change 1 year to 3 years 21.4 (95%CI: 22.6 to 20.3) 21.2 (95%CI: 22.0 to 20.4) 20.5 (95%CI: 21.5 to 0.4) 0.0 (95%CI: 21.6 to 1.6) 0.35
Mean SF-36 MCS
Pre-op 48.1 (95%CI: 46.4 to 49.8) 48.0 (95%CI: 46.8 to 49.1) 47.1 (95%CI: 45.8 to 48.5) 42.0 (95%CI: 40.0 to 43.9) ,0.01
1 year 49.4 (95%CI: 47.9 to 51.0) 50.7 (95%CI: 49.6 to 51.7) 48.7 (95%CI: 47.3 to 50.0) 45.0 (95%CI: 43.1 to 46.9) ,0.01
Change Pre op to 1 year 1.3 (95%CI: 20.1 to 2.8) 2.7 (95%CI: 1.7 to 3.7) 1.5 (95%CI: 0.2 to 2.8) 3.0 (95%CI: 1.0 to 5.1) 0.26
Change 1 year to 3 years 20.6 (95%CI: 22.1 to 0.9) 22.1 (95%CI: 23.2 to 21.1) 20.4 (95%CI: 21.6 to 0.8) 22.1 (95%CI: 24.2 to 0.0) 0.11
p values (ANOVA) represents presence of a difference between any of the four groups.
doi:10.1371/journal.pone.0059079.t002
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SF-36
For the entire study cohort the mean pre-operative physical
(PCS) and mental (MCS) component scores were 27.4 (95%CI
27.0 to 27.8) and 47.0 (95%CI 46.2 to 47.7) respectively. The
corresponding 3 year scores were 36.7 (95%CI 36.0 to 37.4) and
48.5 (95%CI 47.7 to 49.3).
In similarity to the WOMAC score the PCS demonstrated
a significant improvement from the pre-operative level at 1 year
(9.5 (95%CI 9.0 to 10.0)) with scores plateauing thereafter (change
between 1 and 3 years (20.2 (95%CI –1.0 to20.6) (Figure 2). The
observed improvements for the MCS were small and at 3 years
this score had almost returned to its pre-operative level (Table 2
and Figure 3). A breakdown of PCS and MCS scores for each of
the 4 BMI groups is given in table 2 which again demonstrated
a significant trend for decreasing pre-operative and post-operative
scores as BMI increased (both p,0.01).
In contrast to the pattern observed with the WOMAC score
there was a significantly smaller improvement in the PCS at 1 year
for the obese II/III group when compared to the other three BMI
groups (difference versus normal BMI= 2.7 (95%CI: 0.2 to
5.2),p = 0.03; difference versus overweight = 2.8 (95%CI: 0.6 to
5.0),p,0.01; difference versus obese I = 2.4 (95%CI: 0.1 to
4.7),p = 0.04). These difference remained even after adjustment
for the variation in patient demographics between the groups
(adjusted difference between obese II/II versus normal BMI= 1.6
(0.8 to 2.4),p,0.01). There were no significant differences in the
improvement in the PCS improvement at 1 year between the
normal, overweight and obese I groups. The smaller improve-
ments to one year were however balanced by the observation that
the PCS decreased for the normal, overweight and obese I groups
BMI group between 1 and 3 years but marginally improved for the
obese II/III group. Therefore if the magnitude of the improve-
ment from the pre-operative level out to 3 years was considered
there were no significant differences in the PCS improvement
between the 4 groups. The observed change in the MCS was small
for all groups. No significant differences were observed between
the groups for the MCS improvement at 1 year (p = 0.26) and
between 1 and 3 years (p = 0.11) (Table 2).
Satisfaction/Quality of Life
At 1 and 3 years the proportions of patients reporting they were
very or somewhat satisfied with the overall result of their TKR
were 90.0% and 90.4% respectively. The levels of satisfaction
varied for each of the assessment modalities (house or yard work,
recreational activities, pain relief, overall satisfaction) dependent
upon the BMI group (Figures 4 and 5). For each modality
satisfaction decreased as BMI increased with the lowest levels of
satisfaction observed in the obese II/III group. At 3 years the
proportion of patients reporting they were very or somewhat
satisfied was significantly lower in the obese II/III groups when
Figure 2. Mean SF-36 Physical Component Score for each of the 4 BMI groups.
doi:10.1371/journal.pone.0059079.g002
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compared to the normal BMI group for all modalities (Satisfaction
with pain relief: Normal = 93.9% versus Obese II/
III = 84.0%,p,0.01; Satisfaction with house or yard work:
Normal = 86.4% versus Obese II/III = 75.0%,p= 0.01; Satisfac-
tion with recreational activity: Normal = 84.4% versus Obese II/
III = 67.6%,p,0.01; Overall satisfaction: Normal = 93.3% versus
Obese II/III = 84.6%,p= 0.01).
At 3 years a greater proportion of patients in the normal BMI
group reported ‘great or moderate improvements’ in their quality
of life when compared to the other BMI groups (Table 3). The
proportion of patients reporting their quality of life was worse was
highest in the obese II/III group (6.4%). Overall 77.8% of patients
reported they would undergo knee replacement again but the
proportion again varied dependent upon the BMI group with the
highest proportion in the normal group (82.2%) and the lowest in
the Obese II/III group (69.6%),p,0.01) (Table 3).
Discussion
This study has demonstrated that patients achieve equivalent
improvements in knee function and general health outcomes 3
years after TKR irrespective of their pre-operative BMI. These
improvements are achieved by 1 year following surgery and are
maintained at 3 years. Whilst the absolute post-operative
functional scores were lower in patients classified as obese and
morbidly obese the improvements they experienced were compa-
rable to those of patients with lesser BMIs. However, despite
similar functional improvements the obese and morbidly obese
patients had the lowest levels of satisfaction, stated their quality of
life was poorer and were less likely to undergo similar surgery
again.
This study has the following limitations. Firstly BMI was
calculated from patient self-reported height and weight rather than
objective measures. However, previous studies have demonstrated
that patient reported height and weight are accurate reflections of
true height and weight in both the malnourished and overweight/
obese population [23,24]. Secondly our data did not originate
from a single surgeon but instead came from an institutional
registry which included data from several surgeons, introducing
variability in patient selection and surgical management. Registry
data was collected prospectively, however, the study was
retrospective in design and some patients had to be excluded
due to missing data. In addition we only collected data to 3 years
and longer-term data is required to confirm the findings of this
mid-term analysis. Thirdly, our institutional registry does not
collect additional clinically relevant outcome data such as post-
operative complications, length of hospital stay, readmission rates
or radiological outcomes. Fourthly the measures of quality of life
and further surgery used in this study have not been validated,
which limits our ability to draw conclusions from these data.
Fifthly we were not sufficiently powered to analyse the obese II
and III categories separately meaning differences between patients
Figure 3. Mean SF-36 Mental Component Score for each of the 4 BMI groups.
doi:10.1371/journal.pone.0059079.g003
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Figure 4. 1 and 3 year satisfaction with house/yard work (Housework) and recreational activities (Recreation). Key for BMI groups:
1 =Normal BMI, 2 =Overweight, 3 =Obese class I, 4 =Obese class II/III.
doi:10.1371/journal.pone.0059079.g004
Figure 5. 1 and 3 year satisfaction with relief of pain (Pain) and overall satisfaction (Overall). Key for BMI groups: 1 =Normal BMI,
2 =Overweight, 3 =Obese class I, 4 =Obese class II/III.
doi:10.1371/journal.pone.0059079.g005
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at the top end of the BMI spectrum could not be determined,
limiting the usefulness of the study in centres where surgeons
restrict surgery for patients with a BMI of more than 40. Finally,
we were unable to obtain data about other important factors
known to influence patient satisfaction, limiting our understanding
of the differences between our BMI groups. In particular, mental
health scores, level of education and patient expectations are all
known to influence satisfaction after TKR [25,26]. Significant
differences in the distribution of these factors between our BMI
groups could therefore be a further source of confounding.
Furthermore, we did not consider the impact of weight change
after surgery on outcomes in this analysis.
Previous systematic reviews have reported higher mid-term
failure and complication rates in obese and morbidly obese patient
undergoing TKR [10,11]. However, they have been unable to
determine the effect of BMI upon functional outcomes because of
a lack of published evidence [10,11]. Recent work from the
National Joint Registry for England and Wales (NJR) using patient
reported Oxford Knee and Euroqol-5D Scores suggested that
despite lower post-operative scores, patients with morbid obesity
achieve equivalent functional improvements to patients with
a ‘normal’ BMI. Unfortunately this analysis was based on a single
assessment of physical functioning at a median of 7 months
following surgery [9]. Similarly, we have also found that despite
lower pre and post-operative knee specific and general health
scores, overall improvements were similar irrespective of patient
BMI. In addition this study importantly demonstrates that these
findings are valid across different measurement tools, are
maintained at up to 3 years post-surgery, do not change with
repeated measurement and are consistent even after adjustment
for differences in patients demographics between the BMI groups.
While all four BMI groups demonstrated clinically relevant
improvements in the WOMAC score the improvements in the SF-
36 physical and mental component scores were more modest. The
minimally clinically important difference for the SF-36 compo-
nents is 10 points [18]. At 3 years the mean improvement for all
groups fell below this 10 point threshold for both components.
This highlights that TKR primarily effects knee function and as
such the value of this procedure should primarily be assessed by its
effect on the joint rather than the patients overall well-being.
The obese Class II/III group reported the lowest levels of
satisfaction and quality of life compared to other BMI groups. This
finding was consistent across all four satisfaction domains (house or
yard work, recreational activities, pain relief, overall satisfaction).
This contrasts with the study by Stickles et al [27] in which there
was no difference in satisfaction between obese and non-obese
patients but is consistent with the findings reported by Bourne et al
[25] who demonstrated that BMI independently influences patient
reported satisfaction after TKR. While it is likely that BMI
influences patient satisfaction we advise caution when interpreting
the presented data. Factors including mental health status/
depression [28,29]; general health status [29]; need for further
surgery [25,28] and patient expectations [25] are all known to
influence patient satisfaction. As we could not measure and adjust
for these factors they may be a source of confounding. One
explanation for the lower satisfaction observed with increasing
BMI may be that satisfaction is more closely related to the absolute
post-operative functional level rather than the magnitude of any
improvement. The decline in the rates of satisfaction mirrored the
trends for decreasing post-operative WOMAC and SF-36 scores
with increasing BMI lending credence to this idea. Additionally
a number of previous studies have also demonstrated a close
associated between post-operative scores and patient satisfaction
[25,26].
In conclusion, this study has confirmed that obese and morbidly
obese patients gain as much functional benefit from TKR as
patients with lesser BMIs and that this benefit is maintained for up
to 3 years following surgery. However, these patients had lower
absolute post-operative functional scores, were less satisfied and
had poorer quality of life ratings. In addition almost a third of this
patient group would not have the operation again. Contemporary
literature suggests complication and mid-term revision rates
following TKR are similar for obese and morbidly obese patients.
It therefore seems appropriate to pursue knee replacement for this
group as long as patients are made aware that they will not achieve
the same level of function and satisfaction as patients with lesser
BMIs.
Table 3. Responses to questions relating to quality of life and whether patients would undergo TKR again.
BMI group
Assessment
Normal (BMI: 18.5 to
25.0 kg/m2)
Overweight (BMI:
.25.0 to 30.0 kg/m2)
Obese class I (BMI:
.30.0 to 35.0 kg/m2)
Obese class II & III
(BMI: .35.0 kg/m2) TOTAL
p value
(Chi-Squared)
Quality of Life
(Respondents (%))
Great improvement 140 (71.8%) 297 (68.0%) 190 (66.2%) 63 (50.4%) 690 (66.1%) p,0.01
Moderate improvement 34 (17.2%) 83 (19.0%) 50 (17.4%) 31 (24.8%) 198 (19.0%)
Little improvement 8 (4.1%) 31 (7.1%) 29 (10.1%) 16 (12.8%) 84 (8.0%)
No improvement 9 (4.6%) 17 (3.9%) 10 (3.5%) 7 (5.6%) 43 (4.1%)
Quality of life worse 4 (2.1%) 9 (2.1%) 8 (2.8%) 8 (6.4%) 29 (2.8%)
Surgery again?
(Respondents (%))
Yes 157 (82.2%) 336 (77.2%) 227 (79.4%) 87 (69.6%) 807 (77.8%) p,0.01
No 13 (14.3%) 37 (8.5%) 28 (9.8%) 13 (10.4%) 91 (8.8%)
Unsure 21 (11.0%) 62 (14.3%) 31 (10.8%) 25 (20.0%) 139 (13.4%)
doi:10.1371/journal.pone.0059079.t003
BMI and Function after Knee Replacement
PLOS ONE | www.plosone.org 8 March 2013 | Volume 8 | Issue 3 | e59079
Acknowledgments
The authors would like to thank all surgeons contributing patients to the
Freeman arthroplasty register (Prof A McCaskie, Mr N Brewster, Mr D
Weir, Mr J Holland, Mr M Siddique, Mr A Gray, Mr M Hashmi).
Author Contributions
Instigated Freeman joint registry: CG DD. Managed Freeman joint
registry: KB. Conceived and designed the experiments: PB KM CG KB
DD. Performed the experiments: PB KM BK. Analyzed the data: PB KM
BK KB. Contributed reagents/materials/analysis tools: KB CG DD.
Wrote the paper: PB KM CG BK KB DD.
References
1. NHS Information Centre. Available: http://www.ic.nhs.uk/webfiles/
publications/003_Health_Lifestyles/OPAD12/Statistics_on_Obesity_Physical_
Activity_and_Diet_England_2012.pdf. Accessed 21 August 2012.
2. World Health Organisation global infobase (2012) Global comparable estimates
for the prevalence of overweight and obesity. Available: https://apps.who.int/
infobase/?id = 1. Accessed 21 August 2012.
3. Zaninotto P, Head J, Stamatakis E, Wardle H, Mindell J (2009) Trends in
obesity among adults in England from 1993 to 2004 by age and social class and
projections of prevalence to 2012. Journal of epidemiology and community
health 63(2): 140–6.
4. Lohmander LS, Gerhardsson de Verdier M, Rollof J, Nilsson PM, Engstro¨m G
(2009) Incidence of severe knee and hip osteoarthritis in relation to different
measures of body mass: a population-based prospective cohort study. Annals of
the Rheumatic Diseases 68(4): 490–6.
5. Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman B, et al. (1997) Risk
factors for incident radiographic knee osteoarthritis in the elderly: the
Framingham Study. Arthritis and rheumatism 40(4): 728–33.
6. Spector TD, Hart DJ, Doyle DV (1994) Incidence and progression of
osteoarthritis in women with unilateral knee disease in the general population:
the effect of obesity. Ann Rheum Dis 53(9): 565–8.
7. Hochberg MC, Lethbridge-Cejku M, Scott WW Jr, Reichle R, Plato CC, et al.
(1995) The association of body weight, body fatness and body fat distribution
with osteoarthritis of the knee: data from the Baltimore Longitudinal Study of
Aging. The Journal of rheumatology 22(3): 488–93.
8. Kulkarni A, Jameson SS, James P, Woodcock S, Muller S, et al. (2011) Does
bariatric surgery prior to lower limb joint replacement reduce complications?
Surgeon 9(1): 18–21.
9. Baker PN, Petheram T, Jameson SS, Reed MR, Gregg PJ, et al. (2012) The
Association Between Body Mass Index and the Outcomes of Total Knee
Arthoplasty. J Bone Joint Surg [Am] 94(16): 1501–8.
10. Dowsey MM, Choong PFM (2008) Early outcomes and complications following
joint arthroplasty in obese patients: a review of the published reports. ANZ J Surg
78: 439–44.
11. Samson AJ, Mercer GE, Campbell DG (2010) Total knee replacement in the
morbidly obese: a literature review. ANZ J Surg 80: 595–99.
12. Amin AK, Clayton RAE, Patton JT, Gaston M, Cook RE, et al. (2006) Total
knee replacement in morbidly obese patients. Results of a prospective, matched
study. J Bone Joint Surg [Br] 88-B: 1321–6.
13. Suleiman LI, Ortega G, Ong’uti SK, Gonzalez DO, Tran DD, et al. (2012)
Does BMI affect perioperative complications following total knee and hip
arthroplasty? J Surg Res 174(1): 7–11.
14. Yeung E, Jackson M, Sexton S, Walter W, Zicat B, et al. (2011) The effect of
obesity on the outcome of hip and knee arthroplasty. Int Orthop 35(6): 929–34.
15. Dalury DF, Tucker KK, Kelley TC (2012) All-polyethylene tibial components in
obese patients are associated with low failure at midterm follow-up. Clin Orthop
Relat Res 470(1): 117–24.
16. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988)
Validation study of WOMAC: a health status instrument for measuring clinically
important patient relevant outcomes to antirheumatic drug therapy in patients
with osteoarthritis of the hip or knee. J Rheumatol 15(12): 1833–40.
17. Ware JE, Jr., Sherbourne CD (1992) The MOS 36-item short-form health
survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):
473–83.
18. Mahomed N, Gandhi R, Daltroy L, Katz JN (2011) The self-administered
patient satisfaction scale for primary hip and knee arthroplasty. Arthritis:Article
ID: 591253;1–6.
19. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN (2003) The Self-
Administered Comorbidity Questionnaire: a new method to assess comorbidity
for clinical and health services research. Arthritis and rheumatism 49(2): 156–63.
20. Escobar A, Quintana JM, Bilbao A, Arostegui I, Lafuente I, et al. (2007)
Responsiveness and clinically important differences for the WOMAC and SF-36
after total knee replacement. Osteoarthritis Cartilage 15(3): 273–80.
21. National Institutes of Health (2012) Available: http://www.nhlbi.nih.gov/
guidelines/obesity/bmi_tbl.htm.Accessed 9 August 2012.
22. World Health Organisation (2012) Available: http://apps.who.int/bmi/index.
jsp?introPage = intro_3.html.Accessed 12 June 2012.
23. Haverkort EB, de Haan RJ, Binnekade JM, van Bokhorst-de van der Schueren
MA (2012) Self-reporting of height and weight: valid and reliable identification
of malnutrition in preoperative patients. Am J Surg 203(6): 700–7.
24. Dekkers JC, van Wier MF, Hendriksen IJ, Twisk JW, van Mechelen W (2008)
Accuracy of self-reported body weight, height and waist circumference in
a Dutch overweight working population. BMC Med Res Methodol 28;8: 69.
25. Bourne RB, Chesworth BM, Davis AM, Mahomed NN, Charron KD (2010)
Patient satisfaction after total knee arthroplasty: who is satisfied and who is not?
Clin Orthop Relat Res 468(1): 57–63.
26. Scott CE, Howie CR, MacDonald D, Biant LC (2010) Predicting dissatisfaction
following total knee replacement: a prospective study of 1217 patients. J Bone
Joint Surg [Br] 92(9): 1253–8.
27. Stickles B, Phillips L, Brox WT, Owens B, Lanzer WL (2001) Defining the
relationship between obesity and total joint arthroplasty. Obesity Research 9(3):
219–23.
28. Hawker G, Wright J, Coyte P, Paul J, Dittus R, et al. (1998) Health related
Quality of life after Knee Replacement. J Bone Joint Surg [Am] 80(2): 163–173.
29. Anderson JG, Wilson RL, Tsai D, Stulberg SD, Chang RW (1996) Functional
outcome and patient satisfaction in total knee patients over the age of 75. J Arth
11(7): 831–40.
BMI and Function after Knee Replacement
PLOS ONE | www.plosone.org 9 March 2013 | Volume 8 | Issue 3 | e59079
